In recent years, innovative, T-cell based immunotherapeutic strategies have yielded excellent outcomes, with long-lasting results and tumour-specific antitumour activity. During the 25th annual BSMO meeting, Prof. Pierre Coulie (de Duve Institute, Brussels) opened a window on the potential future of immunotherapy in the treatment of cancer
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
